|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0010181,
umls-concept:C0011570,
umls-concept:C0013227,
umls-concept:C0033972,
umls-concept:C0036751,
umls-concept:C0087111,
umls-concept:C0087178,
umls-concept:C0205653,
umls-concept:C0599702,
umls-concept:C1705117,
umls-concept:C2607943,
umls-concept:C2926606
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-3-8
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Many youth with depression do not respond to initial treatment with selective serotonin reuptake inhibitors (SSRIs), and this is associated with higher costs. More effective treatment for these youth may be cost-effective.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1538-3636
|
|
pubmed:author |
pubmed-author:AsarnowJoan RosenbaumJRJr,
pubmed-author:BirmaherBorisB,
pubmed-author:BrentDavidD,
pubmed-author:ClarkeGregG,
pubmed-author:DeBarLynnL,
pubmed-author:DickersonJohn FJF,
pubmed-author:EmslieGrahamG,
pubmed-author:IyengarSatishS,
pubmed-author:KellerMartin BMB,
pubmed-author:KennardBetsyB,
pubmed-author:LynchFrances LFL,
pubmed-author:MayesTarynT,
pubmed-author:McCrackenJames TJT,
pubmed-author:OnoratoMatthewM,
pubmed-author:PortaGiovannaG,
pubmed-author:RyanNeal DND,
pubmed-author:SpiritoAnthonyA,
pubmed-author:StroberMichaelM,
pubmed-author:SuddathRobert LRL,
pubmed-author:VitielloBenedettoB,
pubmed-author:WagnerKaren DKD,
pubmed-author:ZelaznyJamieJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
253-62
|
|
pubmed:meshHeading |
pubmed-meshheading:21383263-Adolescent,
pubmed-meshheading:21383263-Cognitive Therapy,
pubmed-meshheading:21383263-Combined Modality Therapy,
pubmed-meshheading:21383263-Cost-Benefit Analysis,
pubmed-meshheading:21383263-Cyclohexanols,
pubmed-meshheading:21383263-Depressive Disorder, Major,
pubmed-meshheading:21383263-Drug Resistance,
pubmed-meshheading:21383263-Drug Therapy, Combination,
pubmed-meshheading:21383263-Female,
pubmed-meshheading:21383263-Humans,
pubmed-meshheading:21383263-Male,
pubmed-meshheading:21383263-Serotonin Uptake Inhibitors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.
|
|
pubmed:affiliation |
Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97212, USA. frances.lynch@kpchr.org
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Research Support, N.I.H., Extramural
|
